Analyze Diet

Topic:H3N8

H3N8 is an influenza virus subtype that affects horses, resulting in equine influenza, a highly contagious respiratory disease. This virus is characterized by its ability to spread rapidly among equine populations, leading to symptoms such as fever, coughing, nasal discharge, and reduced performance. H3N8 is part of the Orthomyxoviridae family and is known for its potential to mutate, which can complicate control and prevention efforts. Vaccination is a common preventive measure, and biosecurity practices are employed to limit transmission. This page compiles peer-reviewed research studies and scholarly articles that explore the virology, epidemiology, and impact of H3N8 on equine health, including vaccine development and outbreak management strategies.
Potential effectiveness of public health interventions during the equine influenza outbreak in racehorse facilities in Japan, 2007.
Transboundary and emerging diseases    March 14, 2010   Volume 57, Issue 3 162-170 doi: 10.1111/j.1865-1682.2010.01134.x
Nishiura H, Satou K.An outbreak of equine influenza (H3N8) occurred among fully vaccinated racehorses in Japan from August to September, 2007. To assess the potential effectiveness of public health interventions other than vaccination (i.e. movement restriction, isolation and quarantine), which started immediately on the date of detection of the first febrile case, a simple epidemiological model was developed and applied to the observed data. The epidemic curves in five racehorse facilities revealed consistent temporal patterns: (i) a sharp increase in symptom onset of cases during the first 3 days, which is thou...
Isolation and genetic characterization of H3N8 equine influenza virus from donkeys in China.
Veterinary microbiology    January 28, 2010   Volume 144, Issue 3-4 455-460 doi: 10.1016/j.vetmic.2010.01.006
Qi T, Guo W, Huang W, Dai L, Zhao L, Li H, Li X, Zhang X, Wang Y, Yan Y, He N, Xiang W.During the 2007 outbreak of equine influenza (EIV) in China, an influenza virus designated A/donkey/Xinjiang/5/2007 (donkey/Xinjiang/2007) was isolated from a symptomatic donkey in Xinjiang Uygur Autonomous Region, China. To analyze the genetic evolution of the new isolate, the hemagglutinin (HA) gene of donkey/Xinjiang/2007 was amplified and sequenced. Sequence alignment, prediction of glycosylation sites and phylogenetic analysis of the HA1 protein of donkey/Xinjiang/2007 showed most similarity to the Florida sublineage clade 2 of the American lineage of equine influenza viruses. The HA1 seq...
Equine influenza outbreak in India (2008-09): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene.
Veterinary microbiology    January 6, 2010   Volume 143, Issue 2-4 224-237 doi: 10.1016/j.vetmic.2009.12.007
Virmani N, Bera BC, Singh BK, Shanmugasundaram K, Gulati BR, Barua S, Vaid RK, Gupta AK, Singh RK.An outbreak of equine influenza (EI) was reported in India in June, 2008 after a gap of two decades. The outbreak started from Jammu and Kashmir (Katra), northern state of India and spread to the other parts of the country affecting equines in 11 states. The virus (H3N8) was isolated from nasal swabs obtained from clinical cases in various locations in the country including Katra (Jammu and Kashmir), Mysore (Karnataka) and Ahmedabad (Gujarat) using embryonated chicken eggs. The virus isolates were identified as H3N8 by haemagglutination inhibition (HI) test titration with standard serum and by...
Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
Veterinary immunology and immunopathology    November 24, 2009   Volume 135, Issue 1-2 100-107 doi: 10.1016/j.vetimm.2009.11.007
Soboll G, Hussey SB, Minke JM, Landolt GA, Hunter JS, Jagannatha S, Lunn DP.Equine influenza virus remains an important problem in horses despite extensive use of vaccination. Efficacy of equine influenza vaccination depends on the onset and duration of protective immunity, and appropriate strain specificity of the immune response. This study was designed to test the protective immunity resulting from vaccination with the North American commercial ALVAC equine influenza vaccine (RECOMBITEK Influenza, Merial, USA)(1) against challenge with American lineage influenza viruses. In experiment 1, 12 ponies were vaccinated twice, at a 35 day interval, using the ALVAC-influen...
Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus.
Journal of clinical microbiology    October 21, 2009   Volume 47, Issue 12 3907-3913 doi: 10.1128/JCM.00598-09
Lu Z, Chambers TM, Boliar S, Branscum AJ, Sturgill TL, Timoney PJ, Reedy SE, Tudor LR, Dubovi EJ, Vickers ML, Sells S, Balasuriya UB.The objective of this study was to develop and evaluate new TaqMan real-time reverse transcription-PCR (rRT-PCR) assays by the use of the minor groove binding probe to detect a wide range of equine influenza virus (EIV) strains comprising both subtypes of the virus (H3N8 and H7N7). A total of eight rRT-PCR assays were developed, targeting the nucleoprotein (NP), matrix (M), and hemagglutinin (HA) genes of the two EIV subtypes. None of the eight assays cross-reacted with any of the other known equine respiratory viruses. Three rRT-PCR assays (EqFlu NP, M, and HA3) which can detect strains of th...
Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses.
Veterinary microbiology    June 21, 2009   Volume 139, Issue 3-4 351-355 doi: 10.1016/j.vetmic.2009.06.015
Yamanaka T, Nemoto M, Tsujimura K, Kondo T, Matsumura T.In horse populations, influenza A virus subtype H3N8 (equine influenza virus, EIV) is a very important pathogen that leads to acute respiratory disease. Recently, EIV has emerged in dogs, and has become widespread among the canine population in the United States. The interspecies transmission route had thus far remained unclear. Here, we tested whether the interspecies transmission of EIV to dogs could occur as a result of close contact with experimentally EIV-infected horses. Three pairs consisting of an EIV-infected horse and a healthy dog were kept together in individual stalls for 15 conse...
Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007.
Veterinary microbiology    March 13, 2009   Volume 138, Issue 1-2 41-52 doi: 10.1016/j.vetmic.2009.03.004
Bryant NA, Rash AS, Russell CA, Ross J, Cooke A, Bowman S, MacRae S, Lewis NS, Paillot R, Zanoni R, Meier H, Griffiths LA, Daly JM, Tiwari A....Equine influenza virus (EIV) surveillance is important in the management of equine influenza. It provides data on circulating and newly emerging strains for vaccine strain selection. To this end, antigenic characterisation by haemaggluttination inhibition (HI) assay and phylogenetic analysis was carried out on 28 EIV strains isolated in North America and Europe during 2006 and 2007. In the UK, 20 viruses were isolated from 28 nasopharyngeal swabs that tested positive by enzyme-linked immunosorbent assay. All except two of the UK viruses were characterised as members of the Florida sublineage w...
Isolation and characterization of the equine influenza virus causing the 2006 outbreak in Chile.
Veterinary microbiology    December 24, 2008   Volume 137, Issue 1-2 172-177 doi: 10.1016/j.vetmic.2008.12.011
Müller I, Pinto E, Santibáñez MC, Celedón MO, Valenzuela PD.The equine influenza virus is the causal agent of influenza in horses. In July 2006, horses from various regions of Chile presented fever, serious nasal discharge, dry cough, anorexia and depression. Here we describe the isolation and characterization of the virus responsible for this outbreak. The virus was identified as equine influenza virus H3N8, since haemagglutination was inhibited by an anti-A/equi/1/H3N8 serum, but not by an anti-A/equi/1/H7N7 serum. The isolate was named A/equi/2/Lonquén/06 (H3N8). In addition, we describe the isolation and sequencing of the haemagglutinin, neuramini...
Real-time RT-PCR for detection of equine influenza and evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8).
Veterinary microbiology    December 11, 2008   Volume 137, Issue 1-2 1-9 doi: 10.1016/j.vetmic.2008.12.006
Foord AJ, Selleck P, Colling A, Klippel J, Middleton D, Heine HG.Equine influenza (EI) virus (H3N8) was identified in the Australian horse population for the first time in August 2007. The principal molecular diagnostic tool used for detection was a TaqMan real-time reverse transcription-polymerase chain reactions (RT-PCR) assay specific for the matrix (MA) gene of influenza virus type A (IVA). As this assay is not specific for EI, we developed a new EI H3-specific TaqMan assay targeting the haemagglutinin (HA) gene of all recent EI H3 strains. The IVA and the EI H3 TaqMan assays were assessed using in vitro transcribed RNA template, virus culture, diagnost...
Genetic Analyses of an H3N8 Influenza Virus Isolate, Causative Strain of the Outbreak of Equine Influenza at the Kanazawa Racecourse in Japan in 2007.
The Journal of veterinary medical science    October 9, 2008   Volume 70, Issue 9 899-906 doi: 10.1292/jvms.70.899
Ito M, Nagai M, Hayakawa Y, Komae H, Murakami N, Yotsuya S, Asakura S, Sakoda Y, Kida H.In August 2007, an outbreak of equine influenza occurred among vaccinated racehorses with Japanese commercial equine influenza vaccine at Kanazawa Racecourse in Ishikawa prefecture in Japan. Apparent symptoms were pyrexia (38.2-41.0 degrees C) and nasal discharge with or without coughing, although approximately half of the infected horses were subclinical. All horses had been shot with a vaccine that contained two inactivated H3N8 influenza virus strains [A/equine/La Plata/93 (La Plata/93) of American lineage and A/equine/Avesta/93 (Avesta/93) of European lineage] and an H7N7 strain (A/equine/...
Epidemic of equine influenza among vaccinated racehorses in Japan in 2007.
The Journal of veterinary medical science    July 17, 2008   Volume 70, Issue 6 623-625 doi: 10.1292/jvms.70.623
Yamanaka T, Niwa H, Tsujimura K, Kondo T, Matsumura T.On August 2007, we encountered equine influenza epidemic by Florida sub-lineage strain (H3N8) in Japan Racing Association's facilities where 4142 racehorses in total were stabled. The number of new febrile cases sharply increased, but the occurrence was rapidly calmed down within 2 weeks. The morbidity rate in these facilities was 12.8% and the subclinical infection rate of healthy racehorses examined by rapid antigen detection tests was 19.4% at the early stage of epidemic. The serological studies along with the low morbidity rate and the existence of numbers of asymptomatically infected race...
Vaccine failure caused an outbreak of equine influenza in Croatia.
Veterinary microbiology    June 12, 2008   Volume 133, Issue 1-2 164-171 doi: 10.1016/j.vetmic.2008.06.009
Barbic L, Madic J, Turk N, Daly J.In April 2004 an outbreak of equine influenza occurred at the Zagreb hippodrome, Croatia. Clinical respiratory disease of the same intensity was recorded in vaccinated and non-vaccinated horses. The equine influenza vaccine used in Croatia at the time of the outbreak contained the strains A/equine/Miami/63 (H3N8), A/equine/Fontainebleau/79 (H3N8) and A/equine/Prague/56 (H7N7). At the same time, the usual strains in vaccines used in Europe were, in accordance with the recommendation of the World Organisation for Animal Health (OIE) Expert Surveillance Panel on equine influenza, A/equine/Newmark...
Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/EQ/South Africa/4/03 – horse antiserum biological reference preparation.
Pharmeuropa bio    April 17, 2008   Volume 2007, Issue 1 7-14 
Daly J, Daas A, Behr-Gross ME.In 2004, the Office International des Epizooties (OIE) Expert Surveillance Panel on equine influenza recommended that the American lineage component (H3N8) of equine influenza vaccines (A/eq/Newmarket/1/93-like) be updated to an A/eq/South Africa/4/03-like virus. As a consequence the common European Pharmacopoeia (Ph. Eur.) - OIE reference for equine influenza subtype 2 American-like antiserum had to be complemented by an antiserum raised in horses against an A/eq/South Africa/4/03 strain. An international collaborative study run by the European Directorate for the Quality of Medicines (EDQM) ...
Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Veterinary research    February 7, 2008   Volume 39, Issue 3 21 doi: 10.1051/vetres:2007062
Paillot R, Grimmett H, Elton D, Daly JM.In the horse, conventional inactivated or subunit vaccines against equine influenza virus (EIV) induce a short-lived antibody-based immunity to infection. Alternative strategies of vaccination have been subsequently developed to mimic the long-term protection induced by natural infection with the virus. One of these approaches is the use of immune-stimulating complex (ISCOM)-based vaccines. ISCOM vaccines induce a strong antibody response and protection against influenza in horses, humans, and a mouse model. Cell-mediated immunity (CMI) has been demonstrated in humans and mice after ISCOM vacc...
Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study.
Equine veterinary journal    October 4, 2007   Volume 39, Issue 5 446-450 doi: 10.2746/042516407x180327
Daly JM, Sindle T, Tearle J, Barquero N, Newton JR, Corning S.Surveillance of equine influenza viruses has suggested that strains included in currently licensed vaccines are a poor match for those predominantly circulating in the field. Objective: To assess the ability of Duvaxyn IE-T Plus to provide cross protection against the newly evolved South Africa/4/03 (H3N8) strain of equine influenza virus. Methods: The vaccine efficacy was evaluated by challenge infection with influenza strain A/eq/South Africa/4/03 (H3N8) 2 weeks after a primary course of 2 vaccinations with Duvaxyn IE-T Plus given at a 4-week interval. The outcome of challenge in vaccinated ...
Equine influenza in England.
The Veterinary record    June 19, 2007   Volume 160, Issue 24 851 doi: 10.1136/vr.160.24.851
Newton R, Elton D, Bryant N, Rash A, Hammond TA.No abstract available
Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
Journal of comparative pathology    June 7, 2007   Volume 137 Suppl 1 S76-S80 doi: 10.1016/j.jcpa.2007.04.016
Minke JM, Toulemonde CE, Dinic S, Cozette V, Cullinane A, Audonnet JC.A classical limitation of early life immunization is the interference by maternally derived antibodies, which are known to inhibit the immune response to modified-live and killed vaccines. Several studies have convincingly shown that even minute amounts of maternally derived antibodies against equine influenza can strongly interfere with successful vaccination of foals born to immune mares. In this study we evaluated the response of foals born to vaccinated mares to immunization with a canarypox-vectored recombinant vaccine against equine influenza virus H3N8. The recombinant vaccine was able ...
Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
American journal of veterinary research    February 3, 2007   Volume 68, Issue 2 213-219 doi: 10.2460/ajvr.68.2.213
Minke JM, Toulemonde CE, Coupier H, Guigal PM, Dinic S, Sindle T, Jessett D, Black L, Bublot M, Pardo MC, Audonnet JC.To determine onset and duration of immunity provided by a 2- or 3-dose series of a new canarypox-vectored recombinant vaccine for equine influenza virus (rCP-EIV vaccine) expressing the hemagglutinin genes of influenza H3N8 virus strains A/eq/Kentucky/94 and A/eq/Newmarket/2/93 in ponies. Methods: Forty-nine 1- to 3-year-old male Welsh Mountain Ponies that were seronegative for equine influenza virus. Methods: Vaccinated and control ponies were challenged with aerosolized influenza virus A/eq/Sussex/89 (H3N8), representative of the Eurasian lineage of circulating influenza viruses. In trial 1,...
An outbreak of equine influenza virus in vaccinated horses in Italy is due to an H3N8 strain closely related to recent North American representatives of the Florida sub-lineage.
Veterinary microbiology    November 25, 2006   Volume 121, Issue 1-2 56-63 doi: 10.1016/j.vetmic.2006.11.017
Martella V, Elia G, Decaro N, Di Trani L, Lorusso E, Campolo M, Desario C, Parisi A, Cavaliere N, Buonavoglia C.In December 2005, equine influenza virus infection was confirmed as the cause of clinical respiratory disease in vaccinated horses in Apulia, Italy. The infected horses had been vaccinated with a vaccine that contained strains representatives from both the European (A/eq/Suffolk/89) and American (A/eq/Newmarket/1/93) H3N8 influenza virus lineages, and the H7N7 strain A/eq/Praga/56. Genetic characterization of the hemagglutinin (HA) and neuraminidase (NA) genes of the virus from the outbreak, indicated that the isolate (A/eq/Bari/2005) was an H3N8 strain closely related to recent representative...
Efficacy of oseltamivir phosphate to horses inoculated with equine influenza A virus.
The Journal of veterinary medical science    October 5, 2006   Volume 68, Issue 9 923-928 doi: 10.1292/jvms.68.923
Yamanaka T, Tsujimura K, Kondo T, Hobo S, Matsumura T.We investigated the efficacy of the oral administration of oseltamivir phosphate (OP) in horses experimentally infected with equine influenza A virus (H3N8). Nine horses were divided into three horses each of control, treatment and prophylaxis groups. An administration protocol for the treatment group (2 mg/kg of body weight, twice a day for five days) was started immediately after the onset of pyrexia (above 38.9 degrees C). An administration protocol for the prophylaxis group (2 mg/kg of body weight, once a day for five days) was started on a day before viral inoculation. In the treatment gr...
Inability of kaolin treatment to remove nonspecific inhibitors from equine serum for the hemagglutination inhibition test against equine H7N7 influenza virus. Boliar S, Stanislawek W, Chambers TM.The hemagglutination inhibition test is used by many diagnostic and surveillance laboratories for detection of antibodies to influenza viruses. It is well known that the hemagglutination inhibition test is affected by nonspecific inhibitors present in equine serum. Several serum treatments are in use to remove these inhibitors, including treatment with kaolin. Discrepant results were observed in the authors' laboratories when using kaolin treatment before testing equine sera for antibodies against equine influenza virus (EIV) subtype-1 (H7N7). It is demonstrated here that kaolin treatment lead...
Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
Veterinary immunology and immunopathology    April 18, 2006   Volume 112, Issue 3-4 225-233 doi: 10.1016/j.vetimm.2006.02.007
Paillot R, Kydd JH, Sindle T, Hannant D, Edlund Toulemonde C, Audonnet JC, Minke JM, Daly JM.In horses, equine influenza virus (EIV) is a leading cause of respiratory disease. Conventional inactivated vaccines induce a short-lived immune response. By comparison, natural infection confers a long-term immunity to re-infection. An aim of new equine influenza vaccines is to more closely mimic natural infection in order to achieve a better quality of immunity. A new live recombinant vaccine derived from the canarypox virus vector and expressing haemagglutinin genes of EIV (subtype H3N8) has been developed. Stimulation of the immune system was studied after immunisation with this canarypox-...
Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease.
The Veterinary record    February 14, 2006   Volume 158, Issue 6 185-192 doi: 10.1136/vr.158.6.185
Newton JR, Daly JM, Spencer L, Mumford JA.Between March and May 2003, equine influenza virus infection was confirmed as the cause of clinical respiratory disease among both vaccinated and unvaccinated horses of different breeds and types in at least 12 locations in the UK. In the largest outbreak, 21 thoroughbred training yards in Newmarket, with more than 1300 racehorses, were affected, with the horses showing signs of coughing and nasal discharge during a period of nine weeks. Many of the infected horses had been vaccinated during the previous three months with a vaccine that contained representatives from both the European (A/eq/Ne...
An epizootic of equine influenza in Upper Egypt in 2000.
Revue scientifique et technique (International Office of Epizootics)    May 3, 2005   Volume 23, Issue 3 921-930 doi: 10.20506/rst.23.3.1539
Abd El-Rahim IH, Hussein M.This study describes an epizootic of respiratory tract disease caused by influenza virus infection in a large population of equines in Luxor and Aswan, Upper Egypt, during the winter of 2000. The epizootic started in January and the infection rate reached its peak in February before gradually decreasing until the end of April, 2000. Horses, donkeys and mules of all ages and both sexes were affected. Free movement of the infected equines and direct contact between the animals at markets facilitated the rapid spread of the disease. The cause of the epizootic was established by use of serological...
Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom.
The Veterinary record    April 9, 2005   Volume 156, Issue 12 367-371 doi: 10.1136/vr.156.12.367
Edlund Toulemonde C, Daly J, Sindle T, Guigal PM, Audonnet JC, Minke JM.Fifteen influenza-naive Welsh mountain ponies were randomly assigned to three groups of five. A single dose of a recombinant ALVAC vaccine was administered intramuscularly to five of the ponies, two doses, administered five weeks apart, were administered to five, and the other five served as unvaccinated, challenge controls. Two weeks after the completion of the vaccination programme, the ponies were all challenged by exposure to an aerosol of influenza virus A/eq/Newmarket/5/03. Their clinical signs were scored daily for 14 days according to a standardised scoring protocol, and nasal swabs we...
Characterisation of three equine influenza A H3N8 viruses from Germany (2000 and 2002): evidence for frozen evolution.
Veterinary microbiology    March 30, 2005   Volume 107, Issue 1-2 13-21 doi: 10.1016/j.vetmic.2005.01.010
Borchers K, Daly J, Stiens G, Kreling K, Kreling I, Ludwig H.Reported here are the results of antigenic and genetic characterisation of equine influenza strains causing local outbreaks reported to the Equine Diagnostic Centre in Berlin, Germany. In 2000, equine influenza virus was detected in a nasal swab from a non-vaccinated horse using a rapid diagnostic kit, but was not successfully isolated. Partial direct sequencing of the haemagglutinin (HA1) gene, indicated that the virus was a European lineage H3N8 subtype strain representative of strains isolated in several European countries during 2000. In 2002, two equine influenza viruses were isolated fro...
Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an ‘American lineage’ H3N8 virus.
Vaccine    November 9, 2004   Volume 23, Issue 3 418-425 doi: 10.1016/j.vaccine.2004.01.074
Crouch CF, Daly J, Hannant D, Wilkins J, Francis MJ.Protective responses generated by vaccination with an immuno-stimulating complex (ISCOM)-based vaccine for equine influenza (EQUIP F), containing a new 'American lineage' H3N8 virus, were studied. Seven ponies in the vaccine group received two intramuscular injections of EQUIP F given 6 weeks apart. Aerosol challenge with an A/eq/Newmarket/1/93 reference strain 4 weeks after booster vaccination resulted in clinical signs of infection and viral shedding in 7 influenza-naive control animals whereas the vaccinated ponies were significantly protected from both clinical signs and virus excretion. I...
Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
Vaccine    September 15, 2004   Volume 22, Issue 29-30 4101-4109 doi: 10.1016/j.vaccine.2004.02.048
Daly JM, Yates PJ, Newton JR, Park A, Henley W, Wood JL, Davis-Poynter N, Mumford JA.Two lineages of antigenically distinct equine influenza A H3N8 subtype viruses, American and European, co-circulate. Experiments were conducted in ponies to investigate the protection induced by vaccines containing virus from one lineage against challenge infection with homologous or heterologous virus. Regression analysis showed that vaccinated ponies with average pre-challenge single radial haemolysis (SRH) antibody levels (i.e. 45-190mm2) had a higher probability of becoming infected if they were vaccinated with virus heterologous to the challenge strain than if they were vaccinated with ho...
Current perspectives on control of equine influenza.
Veterinary research    July 9, 2004   Volume 35, Issue 4 411-423 doi: 10.1051/vetres:2004023
Daly JM, Newton JR, Mumford JA.Influenza A viruses of the H3N8 subtype are a major cause of respiratory disease in horses. Subclinical infection with virus shedding can occur in vaccinated horses, particularly where there is a mismatch between the vaccine strains and the virus strains circulating in the field. Such infections contribute to the spread of the disease. Rapid diagnostic techniques are available for detection of virus antigen and can be used as an aid in control programmes. Improvements have been made to methods of standardising inactivated virus vaccines, and a direct relationship between vaccine potency measur...
Alternate circulation of recent equine-2 influenza viruses (H3N8) from two distinct lineages in the United States.
Virus research    March 17, 2004   Volume 100, Issue 2 159-164 doi: 10.1016/j.virusres.2003.11.019
Lai AC, Rogers KM, Glaser A, Tudor L, Chambers T.Phylogenetic and antigenic analyses indicate that recent circulating equine-2 influenza viruses in the United States have been alternating between two genetic and antigenic distinct lineages since 1996. The evolution rates for these two lineages, the Kentucky and the Florida lineage, are very similar. For the earlier isolates in the Kentucky lineage, there are multiple and sequential nonsynonymous substitutions at antigenic sites B and D. However, there are no changes at any of these antigenic sites for KY98 and OK00. In the Florida lineage, except for NY99 with one amino acid substitution at ...